Search results
A pioneer in the field of cancer genomics, his studies on colorectal cancers revealed that they result from the sequential accumulation of mutations in oncogenes and tumor suppressor genes. These studies now form the paradigm for modern cancer research and provided the basis for the notion of the somatic evolution of cancer.
May 2, 2024 · Notable Works: “The Genetics of Cancer”. Subjects Of Study: APC. cancer. dicyclohexylcarbodiimide. genetics. p53. Bert Vogelstein (born June 2, 1949, Baltimore, Md., U.S.) is an American oncologist known for his groundbreaking work on the genetics of cancer.
- The Editors of Encyclopaedia Britannica
People also ask
Who is Bert Vogelstein?
Who is Dr Vogelstein?
Who are Vogelstein & Kinzler?
What is Vogelstein collaborating with?
Dec 17, 2021 · December 17, 2021. Bert Vogelstein, M.D., ranks today, as he has for more than three decades, as the pre-eminent international scientist. The discoveries that led the world to understand that cancer is a genetic disease unfolded one by one in his laboratory.
By Libby Darrell. Bert Vogelstein, M.D. has spent a remarkable 44 years on the faculty at Hopkins after graduating from the School of Medicine in 1974. During that time, he established himself as a pioneer in the field of cancer genetics and became the first scientist to elucidate the molecular basis of a common human cancer.
Mar 23, 2017 · Ludwig Johns Hopkins Co-director Bert Vogelstein speaks about what the past four decades of research has taught us about the mechanics of cancer, what genomics and molecular biology have taught us about it and how all of this information might best be exploited to address the challenges posed by cancer.
Bert Vogelstein, M.D. Understanding Genes and Pathways in a Developing Cancer. Research Area: Cancer Prevention. In the late 1980s, Bert Vogelstein, M.D., became the first scientist to unravel the molecular basis of one of the most common genetic mutations in all cancers: errors in the p53 gene.
Prof. Bert Vogelstein is a Clayton Professor of Oncology and Pathology and a Howard Hughes Medical Institute investigator at Johns Hopkins Medical School and Sidney Kimmel Comprehensive Cancer Center. Prof. Vogelstein is recognized for his seminal contributions to the understanding of cancer genetics and genomics.
